PRESS RELEASES

Media

Press Releases

See our recent news and announcements below. If you have any questions or for media inquiries, please contact info@pyramidbio.com for assistance or see specified media contact details within each release.

Pyramid Biosciences Expands Precision Oncology Pipeline

Waltham, MA, November 16, 2021 –

Pyramid Biosciences, Inc., a clinical-stage biotechnology company developing a portfolio of precision therapies targeting a wide range of diseases, today announced the global licensing of the novel monopolar spindle1 (MPS1) called VRN-08 and a second undisclosed asset from Voronoi Inc., a South Korea- based biotechnology company the develops novel kinase inhibitors and target protein degraders. The milestone-based deal is worth up to $846 million dollars (USD). [click to read more]